Pharma Research
"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...
May 31, 2023 | News
ORSERDU (elacestrant) was approved by the FDA in January 2023 for advanced or metastatic estrogen receptor (ER)-positive, human epidermal growth factor (...
May 30, 2023 | News
Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and...
May 30, 2023 | News
Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of&nb...
May 26, 2023 | News
Singapore University of Social Sciences (SUSS) has launched the inaugural Geronpreneurship Innovation Festival and multiple age-inclusive initiatives ...
May 25, 2023 | News
“It provides opportunity to build a scalable, and truly sustainable supply chain of QS-21 to the pharmaceutical industry. The plentiful sup...
May 23, 2023 | News
Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to del...
May 19, 2023 | News
HitGen will utilize its DNA-encoded library (DEL) technology platform, centered around the design, synthesis and screening of DELs, to identify novel inhib...
May 19, 2023 | News
With this qualification, Discovery gains access to Akoya's PhenoImager® HT workflows, which can provide insights into the tumor microenvironment (...
May 19, 2023 | News
Under the agreement, Asieris Pharmaceuticals will use this patented technology in combination with specific optical imaging agents to conduct research on t...
May 19, 2023 | News
What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia?  ...
May 17, 2023 | News
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 ...
May 16, 2023 | News
LaNova Medicines Ltd. ("LaNova Medicines") announced it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305,...
May 15, 2023 | News
TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million &nbs...
May 12, 2023 | News
Most Read
Bio Jobs
News
Editor Picks